Showing 6,049 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

The search for a cure

Media Monitor: HIV Short Film, “Right To Try”

Editor's pick
TAG
28 December 2021
HIV testing policies & guidelines

American Academy of Pediatrics Advises Universal, Routine HIV Screening in Teens and Biomedical HIV Prevention for Youth at Risk

Editor's pick
American Academy of Pediatrics
28 December 2021
Weight gain & lipodystrophy

Persistent and worsening obesity seen in young people on lifelong antiretroviral treatment

News
28 December 2021
Weight gain & lipodystrophy

Greater weight gain in pregnancy linked to TAF-and-integrase inhibitor combinations

News
27 December 2021
Treatment outcomes & life expectancy

High CD4 Counts Equal Longevity, Except in Heart Disease

Editor's pick
POZ
26 December 2021
Injectable & long-acting HIV treatment

Particulate problem prompts hold on 10 Gilead studies of HIV hopeful lenacapavir

Editor's pick
FiercePharma
26 December 2021
Injectable & long-acting PrEP

GlaxoSmithKline's HIV prevention injectable Apretude threatens Gilead with FDA blessing. But will doctors use it?

Editor's pick
FiercePharma
26 December 2021
Ageing & HIV

Rebecca Mbewe on ageing with HIV – GROWS project Video

December 2021
Pregnancy and vertical transmission

Maternal BMI Influences Infant Weight Gain Regardless of HIV Exposure

Editor's pick
Contagion Live
21 December 2021
History of HIV & AIDS

On the 25th Anniversary of the HIV Treatment Revolution, Folks Remember 'Their' 1996

Editor's pick
TheBody
21 December 2021
New & experimental HIV treatments

Trials of long-acting islatravir for HIV treatment and prevention placed on hold

News
21 December 2021
Coronavirus

Headlines linking people with HIV to COVID variants are at best incomplete, at worst stigmatising

News
20 December 2021
Injectable & long-acting HIV treatment

Merck Announces Clinical Holds on Studies Evaluating Islatravir for the Treatment and Prevention of HIV-1 Infection

Editor's pick
Merck press release
14 December 2021
Treatment outcomes & life expectancy

Uncontrolled HIV causes the majority of deaths in children with HIV in western Kenya

News
14 December 2021
Retention & linkage to care

Many effective interventions that improve HIV outcomes for Black men who have sex with men exist – now they need to be scaled up

News
13 December 2021
Ageing & HIV

Jo Josh on ageing with HIV – GROWS project Video

December 2021
Injectable & long-acting HIV treatment

Long-Acting HIV Therapy Hits a Snag

Editor's pick
POZ
9 December 2021
Injectable & long-acting HIV treatment

The Medicines Patent Pool and the University of Washington sign a licence agreement for an investigational long-acting injectable drug combination candidate for HIV

Editor's pick
Medicines Patent Pool
9 December 2021
Adherence

Digital pill tracks HIV prevention pill adherence with 98 percent accuracy

Editor's pick
European Pharmaceutical Review
9 December 2021
HIV treatment

Doctors Keep Telling Me to Chuck My Longtime HIV Regimen. I’m Not—and Here’s Why

Editor's pick
TheBody
7 December 2021
Pharmaceutical industry

Merck pauses 2 more trials of backbone HIV drug over red flag, raising doubts about multi-pronged R&D strategy

Editor's pick
FierceBiotech
7 December 2021
Treatment outcomes & life expectancy

Susan Cole talks about life expectancy for people living with HIV Video

December 2021
PrEP science

Merck Announces Pause in Enrollment for Two Phase 3 Clinical Trials of Investigational, Once-Monthly, Oral Islatravir for Pre-Exposure Prophylaxis (PrEP) of HIV-1 infection

Editor's pick
BusinessWire
7 December 2021
Treatment guidelines

Community Position Statement: DRV/r Must Urgently Become the Preferred Protease Inhibitor Used in Adult Second-Line ART

Editor's pick
AfroCAB
6 December 2021